Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Equality Challenge Unit announced today that the Department of Oncology and the Nuffield Department of Surgical Sciences have been awarded Athena SWAN silver awards for their commitment to advancing women's careers in academia. The Medical Sciences Division now holds 16 silver awards, with all clinical departments holding silver awards. 

Silver Athena SWAN awards are presented by the Equality Challenge Unit in recognition of an organisation’s response to identified challenges and demonstration of the impact of their equality and diversity policies. 

Attaining the silver award is an important milestone working towards equality and diversity.

Nuffield Department of Surgical Sciences Head of Department, Professor Freddie Hamdy, commented: "We are delighted that the department has been awarded an Athena Swan Silver Award. Our goal is to ensure that the department is a place where everyone is given the support and opportunity to achieve their full potential. We are proud of the positive changes within the department and this award reflects our progress on our journey to ensure we provide an inclusive, diverse and world-class department."

Claire Shingler, Operations Manager in the Department of Oncology, said:  “We are delighted to have achieved the Athena SWAN silver award as these issues are extremely important to us. We have some exceptionally talented scientists and non-research staff in the Department of Oncology, many of whom are women, and we want to celebrate their achievements. Nonetheless, we recognise that in order to nurture and grow this talent, we need to constantly strive to offer an inclusive environment in which both women and men want to study and work and where their careers can flourish."

Related Link

NDS receive Athena SWAN silver award

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.